Voxel-based correlation and combination of 18F-Fluorocholine PET and diffusion-weighted MRI in prostate cancer: a hybrid PET/MRI study

被引:0
|
作者
Lee, Jungmin [1 ]
Choi, Hongyoon [1 ]
Paeng, Jin Chul [1 ]
Cheon, Gi Jeong [1 ]
Cho, Jeong Yeon [2 ]
Kwak, Cheol [3 ]
Lee, Dong Soo [1 ]
Chung, June-Key [1 ]
Kang, Keon Wook [1 ]
机构
[1] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
511
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A Pilot Study of 18F-Fluorocholine Dynamic Time-of-Flight PET/MRI in Newly Diagnosed Intermediate-to-High Risk Prostate Cancer
    Choi, Joon Young
    Yang, Jaewon
    Noworolski, Susan M.
    Behr, Spencer
    Kurhanewicz, John
    Chang, Albert J.
    Simko, Jeffry P.
    Nguyen, Hao G.
    Carroll, Peter R.
    Seo, Youngho
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [32] Intraindividual comparison of 11C-Acetate and 18F-Fluorocholine PET/CT and PET/MRI studies for early recurrent prostate cancer after primary treatment
    Lamanna, Giorgio
    Garibotto, Valentina
    Tabouret-Viaud, Claire
    Rager, Olivier
    Jorcano, Sandra
    Vees, Hans-Joerg
    Seimbille, Yann
    Zaidi, Habib
    Ratib, Osman
    Buchegger, Franz
    Miralbell, Raymond
    Zilli, Thomas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (11) : 842 - 843
  • [33] Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma
    Chang, Joe H.
    Joon, Daryl Lim
    Lee, Sze Ting
    Hiew, Chee-Yan
    Esler, Stephen
    Gong, Sylvia J.
    Wada, Morikatsu
    Clouston, David
    O'Sullivan, Richard
    Goh, Yin P.
    Tochon-Danguy, Henri
    Chan, J. Gordon
    Bolton, Damien
    Scott, Andrew M.
    Khoo, Vincent
    Davis, Ian D.
    EUROPEAN RADIOLOGY, 2014, 24 (03) : 715 - 722
  • [34] Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma
    Joe H. Chang
    Daryl Lim Joon
    Sze Ting Lee
    Chee-Yan Hiew
    Stephen Esler
    Sylvia J. Gong
    Morikatsu Wada
    David Clouston
    Richard O’Sullivan
    Yin P. Goh
    Henri Tochon-Danguy
    J. Gordon Chan
    Damien Bolton
    Andrew M. Scott
    Vincent Khoo
    Ian D. Davis
    European Radiology, 2014, 24 : 715 - 722
  • [35] Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT
    Beheshti, Mohsen
    Rezaee, Alireza
    Geinitz, Hans
    Loidl, Wolfgang
    Pirich, Christian
    Langsteger, Werner
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 55S - 60S
  • [36] Pre-operative 18F-Fluorocholine PET/4D-MRI in primary hyperparathyroidism
    Kaseb, A.
    Aymard, S.
    Poterszman, N.
    Hubele, F.
    Vix, M.
    Imperiale, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S173 - S173
  • [37] Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study
    Björg Jónsdóttir
    Montserrat Alemany Ripoll
    Antonina Bergman
    Ilvars Silins
    Inger Sundström Poromaa
    Håkan Ahlström
    Karin Stålberg
    Cancer Imaging, 21
  • [38] Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study
    Jonsdottir, Bjorg
    Ripoll, Montserrat Alemany
    Bergman, Antonina
    Silins, Ilvars
    Poromaa, Inger Sundstrom
    Ahlstrom, Hakan
    Stalberg, Karin
    CANCER IMAGING, 2021, 21 (01)
  • [39] Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence
    Steiner, Ch.
    Vees, H.
    Zaidi, H.
    Wissmeyer, M.
    Berrebi, O.
    Kossovsky, M. P.
    Khan, H. G.
    Miralbell, R.
    Ratib, O.
    Buhegger, F.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2009, 48 (01): : 1 - 9
  • [40] Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients
    Rager, O.
    Baskin, A.
    Amzalag, G.
    Buchegger, F.
    Miralbell, R.
    Ratib, O.
    Zilli, T.
    Garibotto, V.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (05): : 211 - 216